Skip to content

Clinical trials

Completed Hepatitis B, Chronic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Status: Completed Country / region: Australia Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20054
20074
20082
20091
20111
20123
20142
20151
20161
20173
20184
20202
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences7
Hoffmann-La Roche7
Bristol-Myers Squibb3
Arbutus Biopharma Corporation2
Assembly Biosciences2
Brii Biosciences Limited2
Enyo Pharma2
Novartis2
Novartis Pharmaceuticals2
Vir Biotechnology, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic37
Hepatitis B10
Hepatitis6
DNA Virus Infections1
Fibrosis1
Hepatitis, Chronic1
Liver Diseases1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.